Evidence against in utero transmission of hepatitis B virus
- PMID: 33888887
- DOI: 10.1038/s41575-021-00455-z
Evidence against in utero transmission of hepatitis B virus
Comment in
-
Reply to 'Evidence against in utero transmission of hepatitis B virus'.Nat Rev Gastroenterol Hepatol. 2021 Jun;18(6):445-446. doi: 10.1038/s41575-021-00456-y. Nat Rev Gastroenterol Hepatol. 2021. PMID: 33888888 No abstract available.
Comment on
-
Viral hepatitis and pregnancy.Nat Rev Gastroenterol Hepatol. 2021 Feb;18(2):117-130. doi: 10.1038/s41575-020-00361-w. Epub 2020 Oct 12. Nat Rev Gastroenterol Hepatol. 2021. PMID: 33046891 Review.
References
-
- Terrault, N. A. et al. Viral hepatitis and pregnancy. Nat. Rev. Gastroenterol. Hepatol. 18, 117–130 (2021). - DOI
-
- Cheung, K. W. et al. Immunoprophylaxis Failure of Infants Born to Hepatitis B Carrier Mothers Following Routine Vaccination. Clin. Gastroenterol. Hepatol. 16, 144–145 (2018). - DOI
-
- Wen, W. H. et al. Quantitative maternal hepatitis B surface antigen predicts maternally transmitted hepatitis B virus infection. Hepatology 64, 1451–1461 (2016). - DOI
-
- Huang, H. et al. Increased protection of earlier use of immunoprophylaxis in preventing perinatal transmission of hepatitis B virus. Clin. Infect. Dis. https://doi.org/10.1093/cid/ciaa898 (2020). - DOI - PubMed - PMC
-
- Jourdain, G. et al. Tenofovir versus placebo to prevent perinatal transmission of hepatitis B. N. Engl. J. Med. 378, 911–923 (2018). - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
